Study: NSABP B-30
A three-arm randomized trial to compare adjvant Adriamycin and Cyclophosphamide followed by Taxotere (ACT), Adriamycin and Taxotere (AT), and Adriamycin, Taxotere and Cyclophosphamide (ATC) in Breast Cancer patients with positive axillary lymph nodes.

Study: NSABP B-31
Randomized trial comparing the safety and efficacy of Adriamycin and Cyclophosphamide followed by Taxol to that of Adriamycin and Cyclophosphamide followed by Taxol plus Herceptin in node positive Breast Cancer patients who have tumors that overexpose HER2.

Study: NSABP B-34
Clinical trial comparing adjuvant Clodronate therapy vs. Placebo in early stage breast cancer patients receiving Systemic Chemotherapy and/or Tamoxifen or no therapy.

Study: NAFTA (Sponser SLU)
Clinical trial comparing the Disease Free and Overall Survival of Tamoxifen to Toremifene as Adjuvant Therapy for Breast Cancer.

Study: NSABP B-27.2
Clinical Trial to evaluate the worth of Tumor Biomarkers obtained by Fine Needle Aspiration or Core Biopsy in predicting response to preoperative Chemotherapy and Long Term outcome in patients with operable Breast Cancer being treated on NASBP B-27.

Study: NSABP N9431
Clinical Trial to evaluate the effect of Menstrual Cycle and Surgical Treatment of Breast Cancer.

Study: SLND (Sponser CU)
Accuracy and Significance of Polymerase Chain Reaction detection of Sentinel Node Metastasis in Breast Cancer Patients.